Spots Global Cancer Trial Database for celebrex
Every month we try and update this database with for celebrex cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Celecoxib as a Chemopreventive Agent in Current and Former Smokers | NCT00981201 | Smoking Prevention | Celecoxib Celecoxib Placebo Placebo | 18 Years - 74 Years | M.D. Anderson Cancer Center | |
| Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer | NCT00486460 | Pancreatic Canc... | Gemcitabine Curcumin Celebrex | 18 Years - | Tel-Aviv Sourasky Medical Center | |
| Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer | NCT00527982 | Head and Neck C... Lung Cancer | Celecoxib | 18 Years - | M.D. Anderson Cancer Center | |
| Celebrex and Metformin for Postoperative Hepatocellular Carcinoma | NCT03184493 | Liver Cancer | Celebrex plus M... Celebrex Metformin | 18 Years - 75 Years | Guangxi Medical University | |
| Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas | NCT02115074 | Glioma | Fluvastatine Celebrex | 6 Years - 21 Years | Centre Oscar Lambret | |
| Window of Opportunity Study Targeting the Inflammatory Milieu | NCT01881048 | Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | Omega-3 fatty a... Celecoxib | 18 Years - 50 Years | University of Colorado, Denver | |
| Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers | NCT01021215 | Tobacco Use Dis... | Zileuton Celecoxib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas | NCT01258868 | Mesolthelioma Esophageal Canc... Lung Cancer Thoracic Sarcom... Thymoma | Celebrex Tumor cell vacc... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers | NCT01021215 | Tobacco Use Dis... | Zileuton Celecoxib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Celebrex (Celecoxib) Treatment of Laryngeal Papilloma | NCT00592319 | Laryngeal Papil... | Celebrex PDL CO2 laser or mi... | 18 Years - 64 Years | Boston University | |
| Celecoxib as a Chemopreventive Agent in Current and Former Smokers | NCT00981201 | Smoking Prevention | Celecoxib Celecoxib Placebo Placebo | 18 Years - 74 Years | M.D. Anderson Cancer Center | |
| Celecoxib as a Chemopreventive Agent in Current and Former Smokers | NCT00981201 | Smoking Prevention | Celecoxib Celecoxib Placebo Placebo | 18 Years - 74 Years | M.D. Anderson Cancer Center | |
| CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) | NCT00346801 | Lung Cancer | Celecoxib Cisplatin CPT-11 Concurrent Thor... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Medical Treatment of "High-Risk" Neurofibromas | NCT00846430 | Neurofibromatos... | Peg-Interferon ... Celecoxib (Cele... Temozolomide (t... Vincristine Sul... | 2 Years - 30 Years | Spectrum Health Hospitals | |
| Medical Treatment of "High-Risk" Neurofibromas | NCT00846430 | Neurofibromatos... | Peg-Interferon ... Celecoxib (Cele... Temozolomide (t... Vincristine Sul... | 2 Years - 30 Years | Spectrum Health Hospitals | |
| Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers | NCT00503035 | Familial Adenom... | Celecoxib Colonoscopy Bio... | 16 Years - | M.D. Anderson Cancer Center | |
| CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) | NCT00346801 | Lung Cancer | Celecoxib Cisplatin CPT-11 Concurrent Thor... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) | NCT00346801 | Lung Cancer | Celecoxib Cisplatin CPT-11 Concurrent Thor... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases | NCT00080782 | Metastatic Canc... Prostate Cancer | Celecoxib Doxorubicin Hyd... Strontium chlor... | - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
